Schmiesing Andrew M, Ridley T J, Macalena Jeffrey A
University of Minnesota Twin Cities, Minneapolis, Minnesota.
JBJS Essent Surg Tech. 2018 Nov 14;8(4):e29. doi: 10.2106/JBJS.ST.17.00066. eCollection 2018 Dec 26.
Large cartilage defects in the knee are debilitating for patients and challenging for surgeons to treat. Autologous chondrocyte implantation (ACI) has gained popularity over the past 20 years and has become the treatment of choice for large cartilage defects for some surgeons. Termed matrix-applied ACI (MACI), use of autologous chondrocytes cultured on porcine collagen membrane has recently been approved by the U.S. Food and Drug Administration for the treatment of symptomatic full-thickness cartilage defects in the knee. This new technique for cartilage repair is the third generation of chondrocyte implantation technology and the first to involve the use of a scaffolding to grow chondrocytes. MACI is a simpler technique than previous generations and has more reliable chondrocyte seeding. Research has shown that patients do well postoperatively, with improvements in patient-reported outcome out to 5 years postoperatively. These improvements are statistically greater for patients who underwent MACI when compared to those who underwent microfracture. (1) Preoperative evaluation: patients are indicated for a cartilage procedure after magnetic resonance imaging (MRI) and clinical examination. (2) Stage 1: a diagnostic arthroscopy is performed, and chondrocytes are harvested and cultured. (3) Approach: a short vertical incision is made, followed by a medial parapatellar arthrotomy. (4) Debridement: the lesion is identified and debrided back to stable cartilage. (5): Hemostasis: hemostasis is obtained with an epinephrine-soaked sponge. (6) Template creation: foil is used to create a template of the lesion. (7) Cells cutting: with use of the foil, the membrane of cells is cut to the appropriate size and shape. (8) Implantation: the cut membrane is placed on the lesion and secured with fibrin glue. (9) Testing: the knee is taken through a range of motion and the stability of the membrane is confirmed. (10) Closure: standard closure in layers is performed.
膝关节的大面积软骨缺损会使患者身体衰弱,对外科医生的治疗也颇具挑战。在过去20年里,自体软骨细胞移植(ACI)越来越受欢迎,对一些外科医生而言,它已成为大面积软骨缺损的首选治疗方法。使用在猪胶原蛋白膜上培养的自体软骨细胞的基质应用ACI(MACI)最近已获美国食品药品监督管理局批准,用于治疗膝关节有症状的全层软骨缺损。这种软骨修复新技术是第三代软骨细胞移植技术,也是首个涉及使用支架来培养软骨细胞的技术。MACI是一种比前几代技术更简单的技术,软骨细胞播种更可靠。研究表明,患者术后恢复良好,患者报告的术后5年结果均有改善。与接受微骨折手术的患者相比,接受MACI手术的患者在统计学上这些改善更为显著。(1)术前评估:经磁共振成像(MRI)和临床检查后,患者适合进行软骨手术。(2)第一阶段:进行诊断性关节镜检查,采集并培养软骨细胞。(3)入路:做一个短的垂直切口,然后进行内侧髌旁关节切开术。(4)清创:识别病变并清创至稳定的软骨。(5)止血:用浸有肾上腺素的海绵止血。(6)模板制作:用箔片制作病变的模板。(7)细胞切割:使用箔片,将细胞膜切割成合适的大小和形状。(8)植入:将切割好的膜放置在病变处,并用纤维蛋白胶固定。(9)测试:使膝关节进行一系列活动,确认膜的稳定性。(10)缝合:进行标准的分层缝合。